Table 2 Baseline clinical characteristics regarding development of severe diabetic retinopathy
No retinopathy | Retinopathy | p value | |
|---|---|---|---|
N | 1351 | 261 | |
Sex (men %) | 44.3 | 48.1 | 0.261 |
Age (years) | 37.3 ± 11.9 | 35.6 ± 11.7 | 0.036 |
Duration of diabetes (years) | 18.7 ± 12.0 | 19.8 ± 9.8 | 0.160 |
BMI (kg/m2) | 25.1 ± 3.6 | 25.5 ± 3.5 | 0.048 |
WHR men | 0.90 ± 0.07 | 0.90 ± 0.07 | 0.755 |
WHR women | 0.82 ± 0.06 | 0.82 ± 0.06 | 0.211 |
SBP (mmHg) | 131 ± 16 | 134 ± 17 | 0.003 |
DBP (mmHg) | 78 ± 9 | 80 ± 10 | 0.001 |
HbA1c (%) | 8.0 ± 1.2 | 9.1 ± 1.6 | < 0.001 |
HbA1c (mmol/mol) | 64 ± 14 | 76 ± 17 | < 0.001 |
Total cholesterol (mmol/l) | 4.75 ± 0.84 | 4.94 ± 0.89 | 0.001 |
HDL cholesterol (mmol/l) | 1.49 ± 0.40 | 1.37 ± 0.40 | < 0.001 |
LDL cholesterol (mmol/l) | 2.80 ± 0.77 | 2.98 ± 0.79 | 0.001 |
Triglycerides (mmol/l) | 0.92 (0.71–1.28) | 1.04 (0.82–1.53) | < 0.001 |
AHT (%) | 20.8 | 31.3 | < 0.001 |
Beta-blockers (%) | 5.3 | 5.4 | 0.944 |
Ever-smokers (%) | 41.5 | 49.2 | 0.023 |
eGFR | 99 ± 21 | 99 ± 21 | 0.941 |